Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
METTL3 inhibitors target methyltransferase-like 3 (METTL3), the catalytic RNA methyltransferase subunit. METTL3 forms a heterodimer with methyltransferase-like 14 (METTL14), in which METTL3 binds the methyl donor S-adenosylmethionine (SAM). The complex deposits N6-methyladenosine (m6A), the most abundant internal modification of messenger RNA (mRNA). These m6A marks influence mRNA splicing, export, translation and decay through dedicated reader proteins. Selective inhibition of METTL3 slowed the growth of acute myeloid leukemia (AML) models, which drew wide interest to the enzyme. STM2457 and UZH2 bind the SAM pocket of METTL3, and STC-15 is a further METTL3 inhibitor. S-adenosylhomocysteine (SAH), the product of the methyl transfer reaction, is also listed. Readers and erasers of the mark have their own categories, YTHDF and FTO.
METTL3 activator-1 (2-Piperazinecarboxylic acid methyl ester dihydrochloride) is an activator of the Mettl3 enzyme, enhancing its expression. This compound plays a critical role in research applications focused on liver fibrosis, providing insights into the underlying molecular pathways and potential therapeutic targets.
METTL3 activator-1 free base is a potent activator of the METTL3, METTL14, and WTAP complexes. This compound enhances HIV-1 p24 virion production and significantly increases the N6-adenosine methylation levels within the viral RNA genome. It serves as a valuable tool for research in viral biology and RNA modification studies.
Out of stock
All 3 sizes